Application

IPAM

imnewrun Biosciences, Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97359213
Filing Date: 04/12/2022

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 97359213
MARK INFORMATION
*MARK iPAM
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT iPAM
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK imnewrun Biosciences, Inc.
INTERNAL ADDRESS A-5F, N Center, 2066, Seobu-ro,
*MAILING ADDRESS Jang-an-gu Suwon-si,
*CITY Gyeonggi-do,
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Korea, South
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
16419
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Korea, South
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceuticals for the treatment of cancer, epigenetic disease, neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune related disorder; Reagents for use in medical genetic testing; Preparations for detecting mutation in prion genes for medical purposes; Diagnostic preparations for medical purposes for detecting presence of mutation in prion genes; medicines for human purposes for the treatment of cancer, epigenetic disease, neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune related disorder; Pharmaceutical preparations for health care; Vaccines; Diagnostic reagents for medical use; Microorganisms for medical purposes; Biotechnological preparation for medical purposes; Cells for medical purposes; Enzymes for medical purposes; Nucleic acid sequences for medical and veterinary purposes
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 042 
*IDENTIFICATION Scientific research in the fields of biomedicine; Pharmaceutical drug development services; Clinical research and development of medicines; Pharmaceutical products evaluation; Research and development of technology for medicinal chemical manufacturing; scientific study and research in the field of medicine; scientific research in the nature of evaluating clinical trials; Testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; Protein analysis; Development of biotechnology; Providing laboratory research services in the field of biology; Research in the field of gene analysis; Research and development in the pharmaceutical and biotechnology fields
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 044 
*IDENTIFICATION Medical and health services relating to DNA, genetics and genetic testing; Genetic testing for medical research and treatment purposes; Provision of genetic testing for medical treatment purposes; Provision of Genetic information for medical treatment purposes; Providing gene therapy for medical treatment purposes; Genetic counseling for medical purposes; Medical diagnostic testing, monitoring and reporting services; DNA analysis for medical purposes; DNA screening for medical purposes
FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
MISCELLANEOUS STATEMENT Applicant's complete address is: A-5F, N Center, 2066, Seobu-ro, Jang-an-gu Suwon-si, Gyeonggi-do, 16419 Republic of Korea
ATTORNEY INFORMATION
NAME DENNIS S. PRAHL
ATTORNEY DOCKET NUMBER 1T22756497
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Ladas & Parry LLP
STREET 1040 Avenue of the Americas
CITY New York
STATE New York
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 10018
PHONE 212-708-1817
FAX 212.246.8959
EMAIL ADDRESS nyustmp@ladas.com
OTHER APPOINTED ATTORNEY Lanning G. Bryer, Bharati Bakshani, Ralph H. Cathcart, Scott J. Lebson and Sebastian Lovera Riso
CORRESPONDENCE INFORMATION
NAME DENNIS S. PRAHL
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE nyustmp@ladas.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) dprahl@ladas.com; MThompson@ladas.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 3
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 1050
*TOTAL FEES PAID 1050
SIGNATURE INFORMATION
SIGNATURE NOT PROVIDED
SIGNATORY'S NAME NOT PROVIDED
SIGNATORY'S POSITION NOT PROVIDED
DATE SIGNED NOT PROVIDED



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 97359213
Filing Date: 04/12/2022

To the Commissioner for Trademarks:

MARK: iPAM (Standard Characters, see mark)
The literal element of the mark consists of iPAM. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, imnewrun Biosciences, Inc., a corporation of Korea, South, having an address of
      A-5F, N Center, 2066, Seobu-ro,
      Jang-an-gu Suwon-si,
      Gyeonggi-do, 16419
      Korea, South
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceuticals for the treatment of cancer, epigenetic disease, neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune related disorder; Reagents for use in medical genetic testing; Preparations for detecting mutation in prion genes for medical purposes; Diagnostic preparations for medical purposes for detecting presence of mutation in prion genes; medicines for human purposes for the treatment of cancer, epigenetic disease, neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune related disorder; Pharmaceutical preparations for health care; Vaccines; Diagnostic reagents for medical use; Microorganisms for medical purposes; Biotechnological preparation for medical purposes; Cells for medical purposes; Enzymes for medical purposes; Nucleic acid sequences for medical and veterinary purposes
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Scientific research in the fields of biomedicine; Pharmaceutical drug development services; Clinical research and development of medicines; Pharmaceutical products evaluation; Research and development of technology for medicinal chemical manufacturing; scientific study and research in the field of medicine; scientific research in the nature of evaluating clinical trials; Testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; Protein analysis; Development of biotechnology; Providing laboratory research services in the field of biology; Research in the field of gene analysis; Research and development in the pharmaceutical and biotechnology fields
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 044:  Medical and health services relating to DNA, genetics and genetic testing; Genetic testing for medical research and treatment purposes; Provision of genetic testing for medical treatment purposes; Provision of Genetic information for medical treatment purposes; Providing gene therapy for medical treatment purposes; Genetic counseling for medical purposes; Medical diagnostic testing, monitoring and reporting services; DNA analysis for medical purposes; DNA screening for medical purposes
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.


Miscellaneous Statement
Applicant's complete address is: A-5F, N Center, 2066, Seobu-ro, Jang-an-gu Suwon-si, Gyeonggi-do, 16419 Republic of Korea


The owner's/holder's proposed attorney information: DENNIS S. PRAHL. Other appointed attorneys are Lanning G. Bryer, Bharati Bakshani, Ralph H. Cathcart, Scott J. Lebson and Sebastian Lovera Riso. DENNIS S. PRAHL of Ladas & Parry LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      1040 Avenue of the Americas
      New York, New York 10018
      United States
      212-708-1817(phone)
      212.246.8959(fax)
      nyustmp@ladas.com
The docket/reference number is 1T22756497.
DENNIS S. PRAHL submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:
      DENNIS S. PRAHL
       PRIMARY EMAIL FOR CORRESPONDENCE: nyustmp@ladas.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): dprahl@ladas.com; MThompson@ladas.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1050 has been submitted with the application, representing payment for 3 class(es).

Declaration

Declaration Signature

Signature: Not Provided    Date: Not Provided
Signatory's Name: Not Provided
Signatory's Position: Not Provided
Signatory's Phone Number: Not Provided
Payment Sale Number: 97359213
Payment Accounting Date: 04/12/2022

Serial Number: 97359213
Internet Transmission Date: Tue Apr 12 15:42:44 ET 2022
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XX-20220412154244938
903-97359213-82080e7b37efee69c526b8a3e4e
1db8ca8bbec07f2a1d1eab13c6dd2b48d94aae1-
DA-42444234-20220412153923711310

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed